These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 21490076)

  • 21. Beneficial effects of one-year growth hormone administration to children with juvenile chronic arthritis on chronic steroid therapy. I. Effects on growth velocity and body composition.
    Touati G; Prieur AM; Ruiz JC; Noel M; Czernichow P
    J Clin Endocrinol Metab; 1998 Feb; 83(2):403-9. PubMed ID: 9467548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular risk, cardiac function, physical activity, and quality of life with and without long-term growth hormone therapy in adult survivors of childhood acute lymphoblastic leukemia.
    Follin C; Thilén U; Osterberg K; Björk J; Erfurth EM
    J Clin Endocrinol Metab; 2010 Aug; 95(8):3726-35. PubMed ID: 20484480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence of second neoplasm in childhood cancer survivors treated with GH: an analysis of GeNeSIS and HypoCCS.
    Woodmansee WW; Zimmermann AG; Child CJ; Rong Q; Erfurth EM; Beck-Peccoz P; Blum WF; Robison LL;
    Eur J Endocrinol; 2013 Apr; 168(4):565-73. PubMed ID: 23359434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth hormone treatment in short children born prematurely--data from KIGS.
    Boguszewski MC; Karlsson H; Wollmann HA; Wilton P; Dahlgren J
    J Clin Endocrinol Metab; 2011 Jun; 96(6):1687-94. PubMed ID: 21430029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic, cardiovascular, and cerebrovascular outcomes in growth hormone-deficient subjects with previous cushing's disease or non-functioning pituitary adenoma.
    Webb SM; Mo D; Lamberts SW; Melmed S; Cavagnini F; Pecori Giraldi F; Strasburger CJ; Zimmermann AG; Woodmansee WW;
    J Clin Endocrinol Metab; 2010 Feb; 95(2):630-8. PubMed ID: 20022992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
    Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dose-dependent effect of growth hormone on final height in children with short stature without growth hormone deficiency.
    Albertsson-Wikland K; Aronson AS; Gustafsson J; Hagenäs L; Ivarsson SA; Jonsson B; Kriström B; Marcus C; Nilsson KO; Ritzén EM; Tuvemo T; Westphal O; Aman J
    J Clin Endocrinol Metab; 2008 Nov; 93(11):4342-50. PubMed ID: 18728172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term safety of recombinant human growth hormone in children.
    Bell J; Parker KL; Swinford RD; Hoffman AR; Maneatis T; Lippe B
    J Clin Endocrinol Metab; 2010 Jan; 95(1):167-77. PubMed ID: 19906787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment.
    Feigerlová E; Diene G; Oliver I; Gennero I; Salles JP; Arnaud C; Tauber M
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4600-8. PubMed ID: 20926543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic profile in growth hormone-deficient (GHD) adults after long-term recombinant human growth hormone (rhGH) therapy.
    Claessen KM; Appelman-Dijkstra NM; Adoptie DM; Roelfsema F; Smit JW; Biermasz NR; Pereira AM
    J Clin Endocrinol Metab; 2013 Jan; 98(1):352-61. PubMed ID: 23162104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-dose growth hormone (GH) treatment in non-GH-deficient children born small for gestational age induces growth responses related to pretreatment GH secretion and associated with a reversible decrease in insulin sensitivity.
    de Zegher F; Ong K; van Helvoirt M; Mohn A; Woods K; Dunger D
    J Clin Endocrinol Metab; 2002 Jan; 87(1):148-51. PubMed ID: 11788639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Type II diabetes mellitus and impaired glucose regulation in Caucasian children and adolescents with obesity living in Germany.
    Wabitsch M; Hauner H; Hertrampf M; Muche R; Hay B; Mayer H; Kratzer W; Debatin KM; Heinze E
    Int J Obes Relat Metab Disord; 2004 Feb; 28(2):307-13. PubMed ID: 14724655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continued growth hormone (GH) treatment after final height is necessary to complete somatic development in childhood-onset GH-deficient patients.
    Attanasio AF; Shavrikova E; Blum WF; Cromer M; Child CJ; Paskova M; Lebl J; Chipman JJ; Shalet SM;
    J Clin Endocrinol Metab; 2004 Oct; 89(10):4857-62. PubMed ID: 15472176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased insulin sensitivity and compensatory hyperinsulinemia after hormone treatment in children with short stature.
    Heptulla RA; Boulware SD; Caprio S; Silver D; Sherwin RS; Tamborlane WV
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3234-8. PubMed ID: 9329345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The growth hormone-insulin-like growth factor axis in glycogen storage disease type 1: evidence of different growth patterns and insulin-like growth factor levels in patients with glycogen storage disease type 1a and 1b.
    Melis D; Pivonello R; Parenti G; Della Casa R; Salerno M; Balivo F; Piccolo P; Di Somma C; Colao A; Andria G
    J Pediatr; 2010 Apr; 156(4):663-70.e1. PubMed ID: 20022338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
    Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychological adaptation in children with idiopathic short stature treated with growth hormone or placebo.
    Ross JL; Sandberg DE; Rose SR; Leschek EW; Baron J; Chipman JJ; Cassorla FG; Quigley CA; Crowe BJ; Roberts K; Cutler GB
    J Clin Endocrinol Metab; 2004 Oct; 89(10):4873-8. PubMed ID: 15472178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Turner syndrome, insulin sensitivity and growth hormone treatment.
    Mazzanti L; Bergamaschi R; Castiglioni L; Zappulla F; Pirazzoli P; Cicognani A
    Horm Res; 2005; 64 Suppl 3():51-7. PubMed ID: 16439845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Near final height in pubertal growth hormone (GH)-deficient patients treated with GH alone or in combination with luteinizing hormone-releasing hormone analog: results of a prospective, randomized trial.
    Mericq MV; Eggers M; Avila A; Cutler GB; Cassorla F
    J Clin Endocrinol Metab; 2000 Feb; 85(2):569-73. PubMed ID: 10690857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.